At baseline and 4 and 8 weeks following treatment, the researchers assessed dry eye symptoms using the Ocular Surface Disease Index, Dry Eye Questionnaire (DEQ-5) and Symptom Assessment in Dry Eye ...

We report herein a case of thyroid mucosa-associated lymphoid tissue (MALT) lymphoma in a patient receiving antithyroid drug therapy for Graves' disease ... therapy for treatment of stage IE ...

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.

The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...

These are known as disease-modifying treatments and have been licensed for private use. Other medications are under review to see if they could be prescribed to people in the very early stages of ...